HUTCHMED (China) Limited (NASDAQ:HCM) Short Interest Down 8.1% in December

HUTCHMED (China) Limited (NASDAQ:HCM) was the recipient of a large drop in short interest during the month of December. As of December 15th, there was short interest totalling 467,900 shares, a drop of 8.1% from the November 30th total of 509,300 shares. Based on an average daily volume of 95,100 shares, the short-interest ratio is currently 4.9 days.

Wall Street Analysts Forecast Growth

Separately, StockNews.com downgraded HUTCHMED from a “buy” rating to a “hold” rating in a research note on Monday, November 18th.

HUTCHMED Stock Up 0.3 %

HCM traded up $0.05 on Wednesday, reaching $14.41. 39,395 shares of the company traded hands, compared to its average volume of 62,801. The stock’s 50 day moving average price is $16.92 and its 200-day moving average price is $17.90. HUTCHMED has a 52-week low of $11.93 and a 52-week high of $21.92. The company has a debt-to-equity ratio of 0.07, a quick ratio of 2.68 and a current ratio of 2.81.

Institutional Investors Weigh In On HUTCHMED

Institutional investors have recently bought and sold shares of the business. Rhumbline Advisers boosted its stake in HUTCHMED by 8.1% during the 2nd quarter. Rhumbline Advisers now owns 7,553 shares of the company’s stock worth $129,000 after acquiring an additional 564 shares during the last quarter. Vanguard Personalized Indexing Management LLC increased its stake in HUTCHMED by 9.7% in the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 13,216 shares of the company’s stock valued at $226,000 after buying an additional 1,168 shares during the last quarter. Public Employees Retirement System of Ohio bought a new stake in HUTCHMED during the third quarter worth about $35,000. China Universal Asset Management Co. Ltd. raised its position in HUTCHMED by 63.7% during the third quarter. China Universal Asset Management Co. Ltd. now owns 5,966 shares of the company’s stock worth $117,000 after acquiring an additional 2,321 shares in the last quarter. Finally, Blue Trust Inc. grew its holdings in HUTCHMED by 638.2% during the third quarter. Blue Trust Inc. now owns 3,536 shares of the company’s stock worth $69,000 after purchasing an additional 3,057 shares during the period. Institutional investors and hedge funds own 8.82% of the company’s stock.

About HUTCHMED

HUTCHMED (China) Ltd. is a holding company, which engages in the research and development, manufacture, and sale of pharmaceuticals and health-oriented consumer products. It operates through the Oncology/Immunology and Other Ventures segments. The Oncology/Immunology segment includes the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases.